MedTech Industry Dynamics
MedTech Industry Dynamics
Stryker has received FDA 510(k) clearance for Sonopet 3, the latest evolution of its ultrasonic bone and soft tissue removal platform, featuring enhanced power, precision, and versatility along with new technologies including RISE and Pulse Control.
Read MoreStryker has announced a strategic alliance with CMR Surgical, including an approximately $400 million preferred equity investment, an exclusive option to acquire CMR Surgical in the future, and an exclusive U.S. sales agency agreement for the Versius Surgical Robotic portfolio.
Read MoreStryker has announced a planned leadership succession effective January 1, 2027, with current President and COO Spencer Stiles appointed Chief Executive Officer and Kevin Lobo transitioning to Executive Chair of the Board of Directors after a 14-year tenure as CEO.
Read MoreStryker has signed a definitive agreement to acquire ZuriMED, developer of the FiberLocker System, a soft tissue augmentation technology designed to address rotator cuff repair failure, strengthening Stryker’s shoulder portfolio across sports medicine and arthroplasty.
Read MoreSiemens Healthineers has been awarded up to $31.1 million by ARPA-H to advance autonomous remote endovascular robotics for acute ischemic stroke treatment, with the goal of enabling long-distance mechanical thrombectomy without direct human input.
Read MoreStryker has announced the full U.S. commercial launch of Mako RPS, a handheld robotic system for total knee replacement that expands the Mako portfolio beyond robotic-arm assisted surgery into a new category of orthopaedic robotics.
Read MoreStryker has launched the TPX HD, a premium small bone power tool designed for challenging orthopaedic procedures including total joint revisions, minimally invasive surgery, and oral maxillofacial procedures, featuring increased torque and faster performance.
Read MoreThe acquisition adds a pulsed CO₂-based intravascular lithotripsy (IVL) platform designed for calcified peripheral arterial disease, complementing Stryker’s existing peripheral vascular offerings ahead of regulatory clearances.
Read MoreStryker has appointed longtime executive Spencer Stiles as its next President and COO, effective January 1, 2026, while promoting Dylan Crotty to Group President of Orthopaedics.
Read MoreStryker has opened a new 140,000-square-foot R&D facility in Bengaluru, strengthening its India footprint and advancing robotics and AI innovation.
Read More
